2013年世界性抗癫痫联合会抗癫痫药使用指南
2022-04-25 11:51:36 来源: 江门 咨询医生
he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
查看信源地址
- 2022-04-27【有关单位】2020年4月11日Lancet研究精选
- 2022-04-252013年世界性抗癫痫联合会抗癫痫药使用指南
- 2022-03-09久坐的危害 久坐不动对身体危害很大
- 2022-02-28癫痫病治疗新方法都有哪些
- 运动或帮助保护1型糖尿病患者β细胞功能
- 怀孕和产后有哪些问题 长辈的观念和现在的医学科学方法有很大的不同?
- 手术学习:颅内脊索瘤内镜下三脑室入路治疗
- 银屑病药物 Brodalumab 自杀倾向副作用AZ 遭受重创
- J Allergy Clin Immunol:IgE对鼻息肉有影响吗?
- 月经性癫痫患者妊娠期癫痫控制更好
- FDA批准Aptiom用于治疗患者癫痫发作
- 胀痛发生了什么事?
- 如何最有效地去除黑头?
- spa中国有五个专业spa会所介绍
- 患者头痛无明显诱因,神经系统检查无明显异常......
- 太极拳教程 简单小运动美容抗衰老
- 癫痫治疗 中医治疗癫痫不用担心
- FDA 批准银屑病新药 ixekizumab
- 不同类型的早期症状
- 夏季生活常识 酷夏保健秘籍你知道多少(2)
- 由于医生的原因,物「沉默」而且很难进入处方
- 特发性癫痫大发作药物治疗的首选
- 智能手机真能成为诊断工具吗?未必!
- 癫痫患者手术评估新型工具
- FDA警告怀孕期间使用丙戊酸钠药物
- 什么样的枕头可以治疗颈椎病?
- 先天性近视 适用于近视患者的食疗
- 20160809家政女皇栏目:陈允斌讲的功效
- 久坐的危害 久坐不动对身体危害很大
- 子宫肌瘤被称为妇科第一肿瘤!当这些症状出现时,你应该保持警惕
- 诺华Cosentyx欧盟批准治疗中重度斑块状银屑病
- 早期抑郁症能治好吗
- 整天时突然抽搐一下 新生儿整天抽搐怎么办
- 瘙痒症冬天预防措施 瘙痒症患者冬天洗浴要点
- 美国神经病学学会的新指南有助医生为HIV患者更好地选择癫痫药物
- 癫痫病的常见病因有哪些
- 常见的癫痫病猝死的症状有哪些
- 癫痫病发病或许是怎么回事
- 小儿癫痫的一时期症状 癫痫的原因
- 泡温泉时不应忽略的真的
- 【用药问答】控制抑郁症患者再抽搐, 可选用的药物不包括?
- 癫痫病的发病心理因素有哪些
- 发作病小发作症状 这些症状就是发作小发作
- 癫痫病的前期有什么征状